Volume 17, Number 2, 107-109, DOI: 10.1023/A:1025324516325

Should ACE Inhibition Always be First-Line Therapy in Heart Failure? Lessons from the CARMEN Study

Willem J. Remme

View Related Documents

Abstract

Fulltext Preview

Image of the first page of the fulltext document